New I-O Targets Herald a Decade of Drugging the Undruggable Published: Jan 16, 2023 By Heather McKenzie Compugen President and CEO Anat Cohen-Dayag, Ph.D./courtesy of Compugen

Published: Feb 08, 2023 By Heather McKenzie Yair Benita, Ph.D., chief technology officer, AION Labs/courtesy of Tsipi Haitovsky Artificial intelligence and machine learning applications are not

Surgical robotics is dominated by various versions of the da Vinci system from Intuitive Surgical, a competent but expensive tool that’s become a standard in

Ofer Sharon, M.D., CEO, OncoHost/company courtesy  Artificial intelligence and machine learning could change the face of cancer diagnostics. Today, physicians may run blood tests to

Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively long

Published: Mar 08, 2023 By Heather McKenzie Pictured: Iris Grossman, Ph.D., chief therapeutics officer, Eleven Therapeutics/company courtesy  With the opportunity to treat spades of infectious diseases,

Cancer therapies have proliferated over the past few decades, improving outcomes for many patients. But this variety requires accurate diagnostics and appropriate decision making to

Israel’s leading annual life science conference and exhibition to be held on May 16-18, 2023, at the David InterContinental Hotel in Tel Aviv TEL AVIV, ISRAEL,

Israeli startup Bone Sci Bio Ltd. is developing a product that treats bones by promoting the formation and repair of their tissue. The firm was set

Israel is host to some 1,600 life sciences companies that employ more than 83,000 people, and the industry attracted a record $1.5 billion in 2018,

More than 30 Israeli companies have accessed support to help bring health and medical technology innovations to the North of England in the last year,